Research
Macro partitioning
Dysbiosis, characterized by an imbalance in bacterial ratios (e.g., increased Firmicutes/Bacteroidetes ratio or decreased Akkermansia muciniphila), drives low-grade systemic inflammation and insulin resistance through the translocation of bacterial lipopolysaccharides (LPS) into the bloodstream.
Maintain gut barrier integrity to prevent metabolic inflammation. This involves avoiding factors that cause dysbiosis (like excessive antibiotics or poor diet) and supporting beneficial bacteria (like Akkermansia muciniphila) which are often depleted in obesity and diabetes.
GoodSupportsHIGH confidence
Disruption of the dynamic interrelation between the host and the microbial communities causes dysbiosis... The rupture of gut barrier provoked by dysbiosis leads to local and systemic inflammation... a chronic inflammatory process through translocation of gut bacterial LPS into the bloodstream initiates a silent metabolic endotoxemia and ultimately obesity-related disorders.
Why this rating
Review article synthesizing multiple animal and human studies establishing the LPS-endotoxemia link.
Source
Gut Microbiome Dysbiosis and Immunometabolism: New Frontiers for Treatment of Metabolic Diseases
José Ernesto Belizário et al. · Mediators of Inflammation · 2018
narrative_reviewCited 349×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →